Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > OH Providers > Gynecologic Oncologists

Dr. Thomas Herzog, MD

Accepting New Patients

(No ratings)

Specializes in: Gynecologic Oncology

Professional interests include: cervical cancer, gynecologic cancer, minimally invasive gynecologic surgery, and more.

2139 Auburn Avenue D Level - Cancer Center
Cincinnati, OH 45219

(513) 585-1544

Dr. Thomas Herzog, MD is a gynecologic oncologist in Cincinnati, OH specializing in gynecologic oncology. Dr. Thomas Herzog, MD is affiliated with University of Cincinnati Health, The Christ Hospital Health Network, University of Cincinnati College of Medicine, CHRIST HOSPITAL MEDICAL SPECIALISTS LLC and UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY LLC.

Office Locations

Address:

3188 BELLEVUE AVENUE
Cincinnati, OH 45219

Address:

2139 Auburn Avenue D Level - Cancer Center
Cincinnati, OH 45219

Address:

7700 University Drive
West Chester, OH 45069

Some issues Dr. Thomas Herzog, MD can help you with:

Robotic Surgery

Robotic surgery is a type of minimally invasive surgery, using a tiny opening to get inside the body instead of making a large cut. It uses small tools attached to a thin robotic arm, which is controlled by the surgeon. Robotic surgery may be referred to by the specific kind of robot that is used. The most advanced robot currently in use is called the da Vinci, and surgery using it is sometimes called da Vinci surgery.

There are many benefits to robotic surgery, both for the patient and the surgeon. Robotic surgery allows for more precise movements and increased control during very delicate surgical procedures. This makes performing surgery accurately much easier for surgeons and reduces fatigue. The smaller 'hand' of the robot can enter the body via a much smaller opening, which reduces the risk of infection and scarring and leads to a faster recovery. The robotic hands also contain tiny moveable cameras among their tools, giving surgeons a much closer view of the procedure than would be possible with traditional surgery.

In The News

“"In AMPECT, advanced malignant PEComa tumors originating from uterine, ovarian, pelvic or retroperitoneal sites had a response to nab -sirolimus consistent with that of the full study population,...”—"Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)", Fox 5 San Diego, March 2024

“to Dr. Thomas Herzog and his entire staff at UC Health Barrett Cancer Center in Cincinnati, who were instrumental in helping Rita enjoy a high quality of life during her battle with cancer.”—"Rita Louise Ferguson", Chicago Tribune, October 2018

“Dr. Thomas J. Herzog, director of gynecologic oncology at the Columbia University Medical Center, said the recommendations were important because the medical profession had until now told women...”—"Symptoms Found for Early Check on Ovary Cancer", The Gadsden Times, June 2007

doctor visit	599

**Ethnicity**
Non-Hispanic White	145
Black	0
Hispanic	57
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	103
From 75 to 84	72
85 and over	21
Less than 65	30

Hypertension	65
High Cholesterol	62
Stroke	0
Ischemic Heart Disease	32
Depression	24
Chronic Kidney Disease	16
Asthma	13
Osteoperosis	17
Atrial Fibrilation	8
Heart Failure	18
Chronic Obstructive Pulmonary Disease	8
Diabetes	36
Dementia	8
Cancer	23

doctor visit	197

**Ethnicity**
Non-Hispanic White	96
Black	0
Hispanic	30
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	52
From 75 to 84	56
85 and over	14
Less than 65	20

Hypertension	63
High Cholesterol	53
Stroke	0
Ischemic Heart Disease	25
Depression	23
Chronic Kidney Disease	21
Asthma	0
Osteoperosis	15
Atrial Fibrilation	9
Heart Failure	17
Chronic Obstructive Pulmonary Disease	0
Diabetes	27
Dementia	10
Cancer	20

Hypertension	62
High Cholesterol	0
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

doctor visit	67

**Ethnicity**
Non-Hispanic White	30
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	23
From 75 to 84	0
85 and over	0
Less than 65	0

Hypertension	61
High Cholesterol	44
Stroke	0
Ischemic Heart Disease	0
Depression	29
Chronic Kidney Disease	29
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	27

doctor visit	120

**Age**
From 65 to 74	28
From 75 to 84	0
85 and over	0
Less than 65	0

Hypertension	70
High Cholesterol	43
Stroke	0
Ischemic Heart Disease	23
Depression	32
Chronic Kidney Disease	40
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	23
Chronic Obstructive Pulmonary Disease	0
Diabetes	28
Dementia	0
Cancer	21

doctor visit	191
hospital care	59
inpatient care	59

**Ethnicity**
Non-Hispanic White	59
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	37
From 75 to 84	14
85 and over	0
Less than 65	0

Hypertension	69
High Cholesterol	53
Stroke	0
Ischemic Heart Disease	30
Depression	39
Chronic Kidney Disease	44
Asthma	0
Osteoperosis	16
Atrial Fibrilation	0
Heart Failure	20
Chronic Obstructive Pulmonary Disease	0
Diabetes	23
Dementia	16
Cancer	23

doctor visit	253
hospital care	42
inpatient care	42

**Ethnicity**
Non-Hispanic White	83
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	58
From 75 to 84	19
85 and over	0
Less than 65	0

Hypertension	62
High Cholesterol	61
Stroke	0
Ischemic Heart Disease	29
Depression	37
Chronic Kidney Disease	43
Asthma	15
Osteoperosis	14
Atrial Fibrilation	0
Heart Failure	17
Chronic Obstructive Pulmonary Disease	11
Diabetes	33
Dementia	13
Cancer	17

doctor visit	182
hospital care	24
inpatient care	24

**Ethnicity**
Non-Hispanic White	78
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	49
From 75 to 84	19
85 and over	0
Less than 65	0

Hypertension	55
High Cholesterol	55
Stroke	0
Ischemic Heart Disease	28
Depression	37
Chronic Kidney Disease	33
Asthma	0
Osteoperosis	13
Atrial Fibrilation	0
Heart Failure	16
Chronic Obstructive Pulmonary Disease	14
Diabetes	26
Dementia	0
Cancer	22

doctor visit	535
hospital care	86
inpatient care	86

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Thomas Herzog, MD for Medicare patients.

The highest averages for the top procedures that Dr. Thomas Herzog, MD treated as a gynecologic oncologist in Cincinnati, OH were hospital care and inpatient care.

doctor visit	269
hospital care	52
inpatient care	52

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Thomas Herzog, MD.

**Gender**
Male	0
Female	54

**Ethnicity**
Black / African American	0
Asian / Pacific Islander	0
Non-Hispanic White	49
Native American / Alaskan Native	0
Hispanic	8
Other	0

**Age**
75 to 84	18
85 and over	3
Less than 65	5
65 to 74	35

Average of Total of Conditions of Medicare patients treated by Dr. Thomas Herzog, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Thomas Herzog, MD treated were hypertension, high cholesterol, chronic kidney disease and depression.

Hypertension	50
High Cholesterol	37
Stroke	0
Ischemic Heart Disease	16
Depression	22
Chronic Kidney Disease	22
Asthma	2
Osteoporosis	7
Heart Failure	11
Chronic Obstructive Pulmonary Disease	3
Diabetes	17
Atrial Fibrillation	1
Cancer	15
Dementia	4

Education & Training

He is certified by the American Board of Ob & Gyn (Obstetrics & Gynecology) and has a state license in New York.

Board Certification: American Board of Ob & Gyn (Obstetrics & Gynecology)

Licensed In: New York

Affiliations & Hospitals

Dr. Thomas Herzog, MD is associated with these hospitals and organizations:

University of Cincinnati Health

The Christ Hospital Health Network

University of Cincinnati College of Medicine

CHRIST HOSPITAL MEDICAL SPECIALISTS LLC

UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY LLC

Ratings & Reviews

Dr. Thomas Herzog, MD does not have any reviews yet, be the first to leave a review of Dr. Thomas Herzog, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Thomas Herzog, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
AstraZeneca Pharmaceuticals LP	$225,422 LYNPARZA $200,611	IMFINZI $1,394	$23,417
GlaxoSmithKline, LLC.	$48,119 ZEJULA $7,547	JEMPERLI $6,693	$33,879
TESARO, Inc.	$42,705 ZEJULA $11,035	ROLAPITANT IV $125	$31,544
Genentech USA, Inc.	$38,392 Avastin $22,685	TECENTRIQ $1,330	$14,376
Clovis Oncology, Inc.	$33,956 Rubraca $33,261	$695
Other	$244,699 FYARRO $30,078	Lenvima $24,111	YONDELIS $18,272	LYNPARZA $10,286	JAKAFI $8,723	Other $153,228

**Types of Payments**
Consulting Fee	$488,304
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$44,590
Travel and Lodging	$41,983
Honoraria	$34,861
Food and Beverage	$23,479
Other	$76

Research Payments

Dr. Thomas Herzog, MD has received 92 research payments totaling $972,805.

Biography

Dr. Thomas Herzog specializes in gynecologic oncology and practices in Cincinnati, OH, The Village of Indian Hill, OH, and West Chester, OH. Dr. Herzog is professionally affiliated with the University of Cincinnati Health and the University of Cincinnati College of Medicine. According to Doctor.com, new patients are welcome to contact his office in Cincinnati, OH.